---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-042525"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2026-06-11T20:32:54+00:00"
generated_at: "2026-06-11T20:41:07.698501+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pacira stockholders elect all three company director nominees; 2011 stock incentive plan fails

## Summary
- All three company nominees (Christie, Hirawat, Wiggans) elected with ~25-28M votes; dissident slate from DOMA defeated with ~4.6M votes.
- 2011 Stock Incentive Plan failed: 14.2M for, 18.4M against; requires >50% approval.
- ESPP approved: 29.1M for, 3.5M against; share reserve increased by 800,000 shares.
- Say-on-pay passed 19.5M for vs 13.1M against; 452K broker non-votes.
- Board committee assignments updated; new chairs: Young (Audit), Yang (People/Comp), Christie (Nominating).

## SEC filing metadata
- accession: 0001628280-26-042525
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2026-06-11T20:32:54+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/pcrx-20260609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-042525
- JSON: https://secwatch.observer/filing/0001628280-26-042525.json
- Plain text: https://secwatch.observer/filing/0001628280-26-042525.txt

## Key facts
- Shareholder Votes
  Pacira BioSciences, Inc. shareholders approved Approval of the Company’s Amended and Restated 2014 Employee Stock Purchase Plan at the 2026-06-09 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 5 — Approval of the Company’s Amended and Restated 2014 Employee Stock Purchase Plan. For Against Abstain Broker Non-Votes 29,089,928 3,497,653 55,974 452,437
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
- Shareholder Votes
  Pacira BioSciences, Inc. shareholders rejected Approval of the Company’s Amended and Restated 2011 Stock Incentive Plan at the 2026-06-09 meeting.
  - Proposal: equity plan
  - Outcome: failed
  - Meeting: 2026-06-09
  source text: Proposal 4 — Approval of the Company’s Amended and Restated 2011 Stock Incentive Plan. For Against Abstain Broker Non-Votes 14,178,418 18,405,754 59,383 452,437
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
- Shareholder Votes
  Pacira BioSciences, Inc. shareholders approved Election of three Class III directors at the 2026-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 1 — Election of three Class III directors to hold office until the 2029 annual meeting of stockholders, and until their respective successors have been duly elected and qualified. Company’s Nominees Nominee: For Withhold Christopher J. Christie 24,963,961 7,675,321 Samit Hirawat 27,950,304 4,688,937 Thomas Wiggans 28,044,841 4,594,438 DOMA Perpetual Capital Management LLC’s Nominees Nominee: For Withhold Oliver Benton Curtis III 4,614,368 28,024,482 Eric de Armas 4,861,350 27,777,500 Christopher Dennis 4,430,726 28,208,124
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
- Shareholder Votes
  Pacira BioSciences, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 32,908,044 138,246 49,702
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
- Shareholder Votes
  Pacira BioSciences, Inc. shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-09 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 3 — Advisory vote to approve the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 19,513,224 13,073,321 57,010 452,437
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.